Vanguard Global Advisers
NEO icon

Vanguard Global Advisers’s NeoGenomics NEO Stock Holding History

Vanguard Global Advisers’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$741K Hold
50,793
– – ﹤0.01% 1925
2026
Q1 		$377K Buy
+50,793
New +$534K ﹤0.01% 2163

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Global Advisers's NEO Position: Q2 2026 in Review

Vanguard Global Advisers held its NeoGenomics (NEO) position steady in Q2 2026 at 50,793 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

Vanguard Global Advisers first reported a position in NEO in Q1 2026 and has held it in 2 quarters since. 263 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Vanguard Global Advisers held 50,793 shares of NeoGenomics worth $741K as of Q2 2026.
  • Vanguard Global Advisers left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1925 holding.
  • Vanguard Global Advisers first reported a position in NeoGenomics in Q1 2026 and has held it in 2 quarters since.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.